BACE1 and Alzheimer disease: Therefore, to address this problem, we investigated the potential of ramalin and its derivatives, which do not target only a specific mechanism of action but exhibit various physiological activities, such as antioxidant, anti-inflammatory, and BACE-1 inhibitory activities, as therapeutic agents for AD.